Held annually in October, this campaign aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.

ESWI participated in the EU Flu Day at the European Parliament, an annual campaign organised by the Steering Group on Influenza Vaccination highlighting the importance of vaccines against influenza, COVID-19 and RSV.

Hosted by the Parliament of the Czech Republic in Prague and ESWI Board Member Roman Prymula, the event brought together key stakeholders in the Czech Republic to discuss and address the critical issues surrounding vaccine uptake.

Four Joint Research Centre (JRC) designed epidemiological and viral kinetics models will enhance understanding of respiratory disease dynamics, contributing to a better preparedness of future infectious disease outbreaks.

IDC organised this session delved into the complex interplay between diabetes and influenza at OPTIONS XII. It was chaired by Kirsty Short, ESWI Associate Member, featured talks by Katina Hulme, Oana Sandulescu and Tor Biering-Sørensen.

Human parainfluenza virus type 3 (HPIV-3) can cause severe respiratory tract infections. There are no convenient small-animal infection models.

Two find that the drugs may shorten hospital stays and decrease the risk of infection in those at high risk for severe illness, and one concludes that timely initiation reduces the risk of death from flu-related pneumonia.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.

ESWI addresses common questions and misconceptions amongst the general public regarding influenza, COVID-19 and RSV. These responses, elaborated by ESWI Board Members and coalition partners, aim to increase public awareness and prevent misinformation.